Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 28, 2020

SELL
$2.65 - $4.03 $2,700 - $4,106
-1,019 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$2.36 - $5.26 $2,404 - $5,359
1,019 New
1,019 $3,000
Q4 2019

Jan 28, 2020

SELL
$4.6 - $5.57 $358,298 - $433,852
-77,891 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$4.99 - $6.16 $24,930 - $30,775
4,996 Added 6.85%
77,891 $401,000
Q2 2019

Jul 25, 2019

SELL
$5.92 - $7.41 $6,245 - $7,817
-1,055 Reduced 1.43%
72,895 $0
Q4 2018

Jan 29, 2019

BUY
$3.99 - $7.82 $295,060 - $578,289
73,950 New
73,950 $547,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $366M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.